Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.
The impact of COVID-19 has proven that we cannot let people with lung conditions continue to be forgotten, says Dr Alison Cook, Chair of the Taskforce for Lung Health.
We hear from emotional trauma expert and renowned healer, Antonia Harman about the role of the mind in dis-ease.
Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
Helen Green, Dementia Specialist Nurse on Dementia UK’s Admiral Nurse Dementia Helpline, charts the causes and progression of vascular dementia.
Jackie Hook, Head Technical Chemist (CChem MRSC) at JLA Ltd underlines the importance of ensuring total infection control in 2021.
The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.
Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.
Diabetics living in the UK are worried about disruption to insulin supplies as a result of Brexit, according to a new social media study.
In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores how modern technology is helping to diagnose Atrial Fibrillation (AF).
Here, Mary Wilson, Paralympic athlete, shares her personal experience and health journey to highlight the importance of supporting disabled female athletes.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, shares her expertise on the transmission of Diarrheagenic E. coli by plants.
Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Open Access Government was privileged to speak with Dr Mary Stephen again, Public Health Expert at the World Health Organization African Region, about suppressing the spread of COVID-19, remaining vigilant and effectively tackling any resurgence.
Gary Lacasse, Executive Director with Kelly Puddister and Patrick Wright from the Canadian AIDS Society, argue that Canada is far behind other G7 countries in eliminating new HIV infections, with a 25.3% increase in new cases reported between 2014 and 2018.
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.